Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Graves

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
The Annals of Pharmacotherapy|May 1, 1995
Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methodsJ M Kerrick, D L Wolff, N M Graves
Epilepsy Research. Supplement|January 1, 1988
Compliant populations: variability in serum concentrationsN M Graves, G B Holmes, I E Leppik
Journal of Palliative Medicine|April 30, 2005
Management of seizures in brain tumor patients at the end of lifeH G Krouwer, J L Pallagi, N M Graves
The Annals of Pharmacotherapy|November 24, 1998
The new generation of antiepileptic drugs: unresolved questionsN M Graves, B E Gidal, F G Gilliam
Epilepsia|October 1, 1983
Bioavailability of rectally administered carbamazepine suspension in dogsN M Graves, R L Kriel, J C Cloyd
Clinical Neuropharmacology|December 1, 1987
Bioavailability of rectally administered lorazepamN M Graves, R L Kriel, C Jones-Saete
Therapeutic Drug Monitoring|January 1, 1986
Phenytoin clearances in a compliant population: description and applicationN M Graves, I E Leppik, E Termond, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1988
Absorption and safety of rectally administered phenytoinR H Fuerst, N M Graves, R L Kriel, et al.
Clinical Pharmacology and Therapeutics|May 1, 1993
Effect of felbamate on carbamazepine and its major metabolitesM L Wagner, R P Remmel, N M Graves, et al.
Epilepsia|March 1, 1989
Effect of felbamate on phenytoin and carbamazepine serum concentrationsN M Graves, G B Holmes, R H Fuerst, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
The Annals of Pharmacotherapy|May 1, 1995
Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methodsJ M Kerrick, D L Wolff, N M Graves
Epilepsy Research. Supplement|January 1, 1988
Compliant populations: variability in serum concentrationsN M Graves, G B Holmes, I E Leppik
Journal of Palliative Medicine|April 30, 2005
Management of seizures in brain tumor patients at the end of lifeH G Krouwer, J L Pallagi, N M Graves
The Annals of Pharmacotherapy|November 24, 1998
The new generation of antiepileptic drugs: unresolved questionsN M Graves, B E Gidal, F G Gilliam
Epilepsia|October 1, 1983
Bioavailability of rectally administered carbamazepine suspension in dogsN M Graves, R L Kriel, J C Cloyd
Clinical Neuropharmacology|December 1, 1987
Bioavailability of rectally administered lorazepamN M Graves, R L Kriel, C Jones-Saete
Therapeutic Drug Monitoring|January 1, 1986
Phenytoin clearances in a compliant population: description and applicationN M Graves, I E Leppik, E Termond, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1988
Absorption and safety of rectally administered phenytoinR H Fuerst, N M Graves, R L Kriel, et al.
Clinical Pharmacology and Therapeutics|May 1, 1993
Effect of felbamate on carbamazepine and its major metabolitesM L Wagner, R P Remmel, N M Graves, et al.
Epilepsia|March 1, 1989
Effect of felbamate on phenytoin and carbamazepine serum concentrationsN M Graves, G B Holmes, R H Fuerst, et al.
Pageof 5